HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

6.935

-0.050-0.72%

Volume:2.61M

Turnover:17.82M

Market Cap:3.00B

PE:1.05K

High:7.150

Open:7.060

Low:6.510

Close:6.985

52wk High:48.800

52wk Low:6.510

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:0.99

T/O Rate:0.81%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:1.91

PE(LYR):1,050.76

PS:5.87

Loading ...

Overview Company News Filings

CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million

Bulletin Express

CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback

Bulletin Express

CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29

CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28

AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery

CF PharmTech Doses First Subject in Phase I Trial for Inhaled Lung Disease Drug

MT Newswires Live

CF PharmTech completes first healthy volunteer dosing in Phase I trial of inhaled ILD therapy ICF004

Bulletin Express

CF Pharmtech Surges Over 10% Intraday as ICF001 Targets Four Indications

Hong Kong Stock Alert: CF PHARMTECH Surges Over 10% in Morning Session as Clinical Approvals for ICF001 Pave the Way for Global Phase I Trials

CF Pharmtech (02652) Secures 2026 Technology Innovation Golden Bull Award, Pushing Boundaries in Inhalation Therapies to Shape the Future of Respiratory Care

CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity

Simply Wall St.

CF Pharmtech Reports Interim Revenue of RMB 210 Million, Up 2.1% Year-on-Year

CF PharmTech FY26 H1 Net Loss Widens to RMB 10.51 Million; Revenue Rises 2.08% to RMB 210.15 Million

CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares

CF PharmTech Releases Revised Articles of Association: Capital Structure, Governance Framework and Dividend Rules Clarified

Bulletin Express

CF PharmTech Files HKEX Next-Day Disclosure Return, Lifts Share Capital with 21,747,700 New H Shares at HKD 13.82 Each

Hong Kong Stock Alert | CF PHARMTECH (02652) Surges Over 20% Intraday on Two New Clinical Approvals for ICF001, Highlighting Long-Acting Inhaled Prodrug Design Edge

Hong Kong Stock Movers | CF PHARMTECH (02652) Surges Over 5% as ICF001 Covers Four Major Indications Including IPF and PPF, with Plans to Launch Phase I Trials Domestically and Overseas

CF PHARMTECH Secures Two Additional Clinical Approvals for ICF001, Expanding Coverage Across Four Major Indications

CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02652/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":6.935,"timestamp":1790755707004,"preClose":6.985,"halted":0,"volume":2613100,"delay":0,"changeRate":-0.007158196134574189,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Closed National Day","change":-0.05,"latestTime":"09-30 16:08:27","open":7.06,"high":7.15,"low":6.51,"amount":17819721,"amplitude":0.091625,"askPrice":6.94,"askSize":2600,"bidPrice":6.935,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":6.985,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0.9903432906718636,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":0.9903432906718636,"shares":432000000,"dividePrice":0,"high":7.15,"amplitude":0.091625,"preClose":6.985,"low":6.51,"week52Low":6.51,"pbRate":"1.91","psRate":"5.87","week52High":48.8,"institutionHeld":0,"latestPrice":6.935,"committee":-0.268293,"eps":0.0066,"divideRate":0,"volume":2613100,"delay":0,"ttmEps":-0.018,"open":7.06,"prevYearClose":35,"prevWeekClose":9.49,"prevMonthClose":6.935,"prevQuarterClose":6.935,"fiveDayClose":9.385,"twentyDayClose":12.7,"sixtyDayClose":17.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-09-30","current":-385.277778,"percent":0.0875,"low":-715.224392,"twenty":394.286263,"median":482.427115,"eighty":2723.843813,"high":3595.964728,"avg":1307.74812,"sd":1266.807687,"marketCap":2818123153},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-28","current":2055.558094,"twenty":420.751477,"median":499.411825,"eighty":2817.123583,"marketCap":5957535925},{"date":"2026-09-04","current":-569.998069,"twenty":413.490204,"median":496.308733,"eighty":2813.278273,"marketCap":4516395257},{"date":"2026-09-11","current":-530.602158,"twenty":411.393271,"median":488.453269,"eighty":2785.197315,"marketCap":4209914329},{"date":"2026-09-18","current":-562.645514,"twenty":401.517047,"median":483.417787,"eighty":2737.610634,"marketCap":4469986257},{"date":"2026-09-25","current":-486.336524,"twenty":397.332771,"median":482.867142,"eighty":2725.301169,"marketCap":3856379052},{"date":"2026-09-30","current":-354.737966,"twenty":394.286263,"median":482.427115,"eighty":2723.843813,"marketCap":2818123153}],"updateTime":1790811294433},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172159307","title":"CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1172159307","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172159307?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:43","pubTimestamp":1790768590,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) disclosed a repurchase of 144,600 H shares on 30 September 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were bought at prices ranging...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189342248","title":"CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1189342248","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189342248?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:04","pubTimestamp":1790687068,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. executed an on-market repurchase of 67,900 H shares on 29 September 2026, paying a total of HK$0.49 million at prices ranging from HK$7.17 to HK$7.24 per share, with a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190768714","title":"CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1190768714","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190768714?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:02","pubTimestamp":1790686935,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that on September 29, 2026, the company spent HK$489,100 to repurchase 67,900 shares, at a repurchase price of HK$7.17 to HK$7.24 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174155305","title":"CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1174155305","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174155305?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:02","pubTimestamp":1790596933,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that on September 28, 2026, it repurchased 125,300 shares for HK$948,800.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197173820","title":"AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1197173820","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197173820?lang=en_us&edition=fundamental","pubTime":"2026-09-23 09:36","pubTimestamp":1790127386,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) recently announced a research collaboration agreement with a tech enterprise founded by a team of scientists with backgrounds in relevant disciplines from a leading domestic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","ARTY","AIPO","QTOC","CHAT","VTHR","02652","159945","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669079118","title":"CF PharmTech Doses First Subject in Phase I Trial for Inhaled Lung Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669079118","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669079118?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:17","pubTimestamp":1790050678,"startTime":"0","endTime":"0","summary":"CF PharmTech  has enrolled and dosed the first healthy subject in the Phase I clinical trial of ICF004, an inhaled drug being developed to treat interstitial lung disease.The Phase I trial will assess the safety, tolerability and pharmacokinetics of single and multiple doses in healthy subjects in China, according to a Monday Hong Kong bourse filing.ICF004 is designed to deliver the drug directly to the lungs to increase local exposure while reducing systemic exposure.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175867609","title":"CF PharmTech completes first healthy volunteer dosing in Phase I trial of inhaled ILD therapy ICF004","url":"https://stock-news.laohu8.com/highlight/detail?id=1175867609","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175867609?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:01","pubTimestamp":1790002905,"startTime":"0","endTime":"0","summary":"CF PharmTech announced the successful enrolment and dosing of the first healthy subject in its Phase I clinical trial evaluating ICF004, an inhalation powder developed for interstitial lung disease...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104672753","title":"CF Pharmtech Surges Over 10% Intraday as ICF001 Targets Four Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104672753","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104672753?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:30","pubTimestamp":1789356623,"startTime":"0","endTime":"0","summary":"Shares of CF Pharmtech (02652) climbed sharply this morning, hitting an intraday peak with a gain exceeding 10%. As of the time of writing, the stock has pared gains to trade up 1.06% at HKD 10.47,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131192332","title":"Hong Kong Stock Alert: CF PHARMTECH Surges Over 10% in Morning Session as Clinical Approvals for ICF001 Pave the Way for Global Phase I Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1131192332","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131192332?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:14","pubTimestamp":1789092852,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares jumped more than 10% early on Thursday before paring gains to trade 8.23% higher at HK$10.39, with turnover reaching HK$28.74 million. The price surge follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02652","BK4585","BK1191","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172001994","title":"CF Pharmtech (02652) Secures 2026 Technology Innovation Golden Bull Award, Pushing Boundaries in Inhalation Therapies to Shape the Future of Respiratory Care","url":"https://stock-news.laohu8.com/highlight/detail?id=1172001994","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172001994?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:06","pubTimestamp":1788750387,"startTime":"0","endTime":"0","summary":"On September 6, 2026, the \"2026 Xiamen Sci-Tech Innovation and Securities Industry Development Conference暨Securities Industry Golden Bull Award Ceremony,\" hosted by China Securities Journal, took...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664631108","title":"CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664631108","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664631108?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:32","pubTimestamp":1788276756,"startTime":"0","endTime":"0","summary":"CF PharmTech stock has already been under pressure, with the share price down about 31% over the past three months, and today’s earnings give investors a clear reason why. The market is reacting to a story that is not about revenue size; it is about profits that have slipped into a loss again.\nThe headline for this half is simple. CF PharmTech generated revenue of C¥210.154 million but reported a net loss of C¥10.506 million and a loss per share. That profit squeeze lands on a stock already...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111083124","title":"CF Pharmtech Reports Interim Revenue of RMB 210 Million, Up 2.1% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1111083124","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111083124?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:07","pubTimestamp":1788185267,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has released its interim results for 2026, posting revenue of RMB 210 million, a 2.1% increase compared to the same period last year. This growth was primarily driven by...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663165006","title":"CF PharmTech FY26 H1 Net Loss Widens to RMB 10.51 Million; Revenue Rises 2.08% to RMB 210.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663165006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663165006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:36","pubTimestamp":1788183360,"startTime":"0","endTime":"0","summary":"CF PharmTech FY26 H1 net loss widens to RMB 10.51 million; revenue rises 2.08% to RMB 210.15 millionCF PharmTech posted a net loss of RMB 10.51 million, worsening from RMB 1.23 million a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL98lX14:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190191183","title":"CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1190191183","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190191183?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:46","pubTimestamp":1787931980,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has announced the completion of a share issuance, marking a significant step in its capital management strategy.According to the company's latest disclosure, on 6 August 2026, CF...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138766694","title":"CF PharmTech Releases Revised Articles of Association: Capital Structure, Governance Framework and Dividend Rules Clarified","url":"https://stock-news.laohu8.com/highlight/detail?id=1138766694","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138766694?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:23","pubTimestamp":1787927004,"startTime":"0","endTime":"0","summary":"CF PharmTech (CF PharmTech, 02652) has published its updated Articles of Association, effective 6 August 2026, detailing the company’s capital structure, shareholder rights and corporate-governance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099896","title":"CF PharmTech Files HKEX Next-Day Disclosure Return, Lifts Share Capital with 21,747,700 New H Shares at HKD 13.82 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099896?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:06","pubTimestamp":1787925970,"startTime":"0","endTime":"0","summary":"CF PharmTech files HKEX next-day disclosure return, lifts share capital with 21,747,700 new H shares at HKD 13.82 eachCF Pharmtech filed a next day disclosure return covering an issuance of 21,747,700","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9qNHrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195250789","title":"Hong Kong Stock Alert | CF PHARMTECH (02652) Surges Over 20% Intraday on Two New Clinical Approvals for ICF001, Highlighting Long-Acting Inhaled Prodrug Design Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=1195250789","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195250789?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:14","pubTimestamp":1787796855,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares climbed more than 20% during intraday trading, last up 6.14% at HK$16.2 with turnover reaching HK$58.31 million.The company recently announced that its self-developed...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VXUS","02652","BK4585","KCAI","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132112506","title":"Hong Kong Stock Movers | CF PHARMTECH (02652) Surges Over 5% as ICF001 Covers Four Major Indications Including IPF and PPF, with Plans to Launch Phase I Trials Domestically and Overseas","url":"https://stock-news.laohu8.com/highlight/detail?id=1132112506","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132112506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:51","pubTimestamp":1787622692,"startTime":"0","endTime":"0","summary":"Shares of CF PHARMTECH (02652) climbed more than 5% in Hong Kong trading, last up 5.46% at HK$16.06 with turnover reaching HK$6.502 million. The company announced that its self-developed long-acting...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02652","BK4585","VXUS","KCAI","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104287705","title":"CF PHARMTECH Secures Two Additional Clinical Approvals for ICF001, Expanding Coverage Across Four Major Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104287705","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104287705?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576431,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its self-developed long-acting inhaled dry powder candidate drug, ICF001, has received implied approval from the National Medical Products Administration to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144024774","title":"CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1144024774","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144024774?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571660,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its independently developed long-acting inhaled dry powder candidate drug, ICF001, has received implied clinical trial approval from the National Medical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BMED","MDTX","PSYK","IBBJ","BK1191","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123,"code":"91000000","status":"200"}]}}